Trails Edge Capital Partners’s ImageneBio IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.01M Buy
1,094,045
+812,041
+288% +$4.41M 0.72% 34
2026
Q2
$1.66M Buy
+282,004
New +$1.59M 0.26% 35

Other funds holding IMA

Trails Edge Capital Partners's IMA Position: Q3 2026 in Review

Trails Edge Capital Partners increased its ImageneBio (IMA) stake by 288% in Q3 2026, buying an estimated $4.41M and bringing the position to 1,094,045 shares worth $5.01M. The position accounts for 0.72% of the portfolio, ranked #34.

Trails Edge Capital Partners first reported a position in IMA in Q2 2026 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold IMA as of Q3 2026.

  • Trails Edge Capital Partners held 1,094,045 shares of ImageneBio worth $5.01M as of Q3 2026.
  • Trails Edge Capital Partners bought 812,041 ImageneBio shares in Q3 2026, an estimated $4.41M.
  • ImageneBio made up 0.72% of Trails Edge Capital Partners's portfolio in Q3 2026, its #34 holding.
  • Trails Edge Capital Partners first reported a position in ImageneBio in Q2 2026 and has held it in 2 quarters since.
  • 37 funds tracked by Wall St. Rank held ImageneBio as of Q3 2026.

Based on Trails Edge Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.